Da Pang

16PUBLICATIONS
36CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisHaematological tumoursMechanobiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 15, 2026
CSF1R inhibitors mitigate CDK4/6 inhibitor-induced immunosuppression to increase antitumor immunity in HR+/HER2- breast cancer.

|Dec 27, 2025
Proteogenomic Characterization Reveals Subtype-Specific Therapeutic Potential for HER2-Low Breast Cancer.

Shouping Xu, Keda Yu, Lei Liu

|Sep 24, 2025
Integrating ctDNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.

Jialin Liu, Fang Fang, Weiguang Yuan

|Jun 20, 2025
An Approach for Differential Diagnosis of Breast Tumors by ctDNA Methylation Sequencing.

Xianyu Zhang, Yanling Yin, Zhujia Ye

|Feb 26, 2022
Unconventional protein post-translational modifications: the helmsmen in breast cancer.

Jiena Liu, Qin Wang, Yujuan Kang

|Sep 01, 2021
Long noncoding RNA SNHG1 promotes TERT expression by sponging miR-18b-5p in breast cancer.

Yujuan Kang, Lin Wan, Qin Wang

Pageof 3

Frequent Collaborators

4 joint publications

Shouping Xu

3 joint publications

Yashuang Zhao

3 joint publications

Xianyu Zhang

2 joint publications

Siwei Li